These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35300300)

  • 1. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
    Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
    Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
    Bian W; Bian W; Li Q; Li Y
    J Gastrointest Cancer; 2024 Jun; 55(2):638-651. PubMed ID: 38557825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
    Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
    J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
    Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
    Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
    Liu Y; Ren T; Xu X; Jin J
    Eur J Cancer Prev; 2022 Jan; 31(1):35-43. PubMed ID: 33470689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.
    Tao Y; Li Y; Liu X; Deng Q; Yu Y; Yang Z
    Cancer Manag Res; 2018; 10():2695-2709. PubMed ID: 30147368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis.
    Abdelmalak J; Tan N; Con D; Eslick G; Majeed A; Kemp W; Roberts SK
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis.
    Pang Q; Jin H; Qu K; Man Z; Wang Y; Yang S; Zhou L; Liu H
    Onco Targets Ther; 2017; 10():4645-4656. PubMed ID: 29033583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Yu Y; Liu L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
    Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
    Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study.
    Chung W; Wong K; Ravindranayagam N; Tang L; Grace J; Wong D; Con D; Sinclair M; Majumdar A; Kutaiba N; Hui S; Gow P; Muralidharan V; Dobrovic A; Testro A
    World J Transplant; 2024 Sep; 14(3):94914. PubMed ID: 39295976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
    He X; Zhao Z; Jiang X; Sun Y
    Front Pharmacol; 2023; 14():1216059. PubMed ID: 37538177
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
    Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
    Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.